BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

581 related articles for article (PubMed ID: 19615356)

  • 1. Morphological changes and molecular expressions of hepatocellular carcinoma cells in three-dimensional culture model.
    Wu YM; Tang J; Zhao P; Chen ZN; Jiang JL
    Exp Mol Pathol; 2009 Oct; 87(2):133-40. PubMed ID: 19615356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced expression of Hab18g/CD147 and activation of integrin pathway in HCC cells under 3-D co-culture conditions.
    Wu YM; Tang J; Zhao P; Chen ZN; Jiang JL
    Cell Biol Int; 2009 Feb; 33(2):199-206. PubMed ID: 19059491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HAb18G/CD147 functions in invasion and metastasis of hepatocellular carcinoma.
    Xu J; Xu HY; Zhang Q; Song F; Jiang JL; Yang XM; Mi L; Wen N; Tian R; Wang L; Yao H; Feng Q; Zhang Y; Xing JL; Zhu P; Chen ZN
    Mol Cancer Res; 2007 Jun; 5(6):605-14. PubMed ID: 17579119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Focal adhesion kinase: important to prostaglandin E2-mediated adhesion, migration and invasion in hepatocellular carcinoma cells.
    Bai XM; Zhang W; Liu NB; Jiang H; Lou KX; Peng T; Ma J; Zhang L; Zhang H; Leng J
    Oncol Rep; 2009 Jan; 21(1):129-36. PubMed ID: 19082453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BetaIg-h3 is involved in the HAb18G/CD147-mediated metastasis process in human hepatoma cells.
    Tang J; Zhou HW; Jiang JL; Yang XM; Li Y; Zhang HX; Chen ZN; Guo WP
    Exp Biol Med (Maywood); 2007 Mar; 232(3):344-52. PubMed ID: 17327467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. siRNA targeted against HAb18G/CD147 inhibits MMP-2 secretion, actin and FAK expression in hepatocellular carcinoma cell line via ERK1/2 pathway.
    Xu HY; Qian AR; Shang P; Xu J; Kong LM; Bian HJ; Chen ZN
    Cancer Lett; 2007 Mar; 247(2):336-44. PubMed ID: 16815629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Annexin II promotes invasion and migration of human hepatocellular carcinoma cells in vitro via its interaction with HAb18G/CD147.
    Zhao P; Zhang W; Tang J; Ma XK; Dai JY; Li Y; Jiang JL; Zhang SH; Chen ZN
    Cancer Sci; 2010 Feb; 101(2):387-95. PubMed ID: 20047591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The glycosylation characteristic of hepatoma-associated antigen HAb18G/CD147 in human hepatoma cells.
    Yu XL; Jiang JL; Li L; Feng Q; Xu J; Chen ZN
    Int J Biochem Cell Biol; 2006; 38(11):1939-45. PubMed ID: 16824781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of HAb18G/CD147 promotes invasion and metastasis via alpha3beta1 integrin mediated FAK-paxillin and FAK-PI3K-Ca2+ pathways.
    Tang J; Wu YM; Zhao P; Yang XM; Jiang JL; Chen ZN
    Cell Mol Life Sci; 2008 Sep; 65(18):2933-42. PubMed ID: 18695939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AMPA receptors promote perivascular glioma invasion via beta1 integrin-dependent adhesion to the extracellular matrix.
    Piao Y; Lu L; de Groot J
    Neuro Oncol; 2009 Jun; 11(3):260-73. PubMed ID: 18957620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. P21-activated protein kinase is overexpressed in hepatocellular carcinoma and enhances cancer metastasis involving c-Jun NH2-terminal kinase activation and paxillin phosphorylation.
    Ching YP; Leong VY; Lee MF; Xu HT; Jin DY; Ng IO
    Cancer Res; 2007 Apr; 67(8):3601-8. PubMed ID: 17440071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fascin-1 expression correlates with repression of E-cadherin expression in hepatocellular carcinoma cells and augments their invasiveness in combination with matrix metalloproteinases.
    Hayashi Y; Osanai M; Lee GH
    Cancer Sci; 2011 Jun; 102(6):1228-35. PubMed ID: 21323792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Focal adhesion kinase mRNA overexpression in hepatocellular carcinoma HCC) and correlation thereof with prognosis of HCC].
    Yuan Z; Fan J; Wu ZQ; Zhou J; Qiu SJ
    Zhonghua Yi Xue Za Zhi; 2007 May; 87(18):1256-9. PubMed ID: 17686260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrin alpha1beta1 and alpha2beta1 are the key regulators of hepatocarcinoma cell invasion across the fibrotic matrix microenvironment.
    Yang C; Zeisberg M; Lively JC; Nyberg P; Afdhal N; Kalluri R
    Cancer Res; 2003 Dec; 63(23):8312-7. PubMed ID: 14678990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Active lysyl oxidase (LOX) correlates with focal adhesion kinase (FAK)/paxillin activation and migration in invasive astrocytes.
    Laczko R; Szauter KM; Jansen MK; Hollosi P; Muranyi M; Molnar J; Fong KS; Hinek A; Csiszar K
    Neuropathol Appl Neurobiol; 2007 Dec; 33(6):631-43. PubMed ID: 17931358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of beta-catenin by hypoxia in hepatocellular carcinoma contributes to enhanced metastatic potential and poor prognosis.
    Liu L; Zhu XD; Wang WQ; Shen Y; Qin Y; Ren ZG; Sun HC; Tang ZY
    Clin Cancer Res; 2010 May; 16(10):2740-50. PubMed ID: 20460486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of growth factor receptor bound protein 7 in hepatocellular carcinoma.
    Itoh S; Taketomi A; Tanaka S; Harimoto N; Yamashita Y; Aishima S; Maeda T; Shirabe K; Shimada M; Maehara Y
    Mol Cancer Res; 2007 Jul; 5(7):667-73. PubMed ID: 17634422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Downregulation of CD147 expression alters cytoskeleton architecture and inhibits gelatinase production and SAPK pathway in human hepatocellular carcinoma cells.
    Qian AR; Zhang W; Cao JP; Yang PF; Gao X; Wang Z; Xu HY; Weng YY; Shang P
    J Exp Clin Cancer Res; 2008 Oct; 27(1):50. PubMed ID: 18847500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The role of FAK expression inhibition by RNA interference on liver cancer cells].
    Yuan Z; Zheng Q; Huang XY; Fan J
    Zhonghua Wai Ke Za Zhi; 2007 Oct; 45(19):1350-3. PubMed ID: 18241574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD147-targeting siRNA inhibits cell-matrix adhesion of human malignant melanoma cells by phosphorylating focal adhesion kinase.
    Nishibaba R; Higashi Y; Su J; Furukawa T; Kawai K; Kanekura T
    J Dermatol; 2012 Jan; 39(1):63-7. PubMed ID: 21967109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.